Viewing Study NCT06849167


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-01-04 @ 2:17 PM
Study NCT ID: NCT06849167
Status: RECRUITING
Last Update Posted: 2025-02-27
First Post: 2025-02-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC
Sponsor: Peking University Cancer Hospital & Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module